Effective November 5th, testing for Beta-2 Glycoprotein 1 antibodies (IgG and IgM, serum) will change from a reference send out test to Mayo Medical Laboratories to an in-house test available at Spectrum Health Laboratories. This testing is useful for evaluation of patients of suspected antiphospholipid antibody syndrome.
In addition, a new Antiphospholipid Antibody Syndrome Panel will be added which allows for appropriate and complete testing for antiphospholipid antibody syndrome. This panel includes:
Cardiolipin IgG and IgM Antibodies
Beta-2 Glycoprotein 1 IgG and IgM Antibodies
This testing panel is consistent with recommendations from the revised Sapporo classification criteria.
Questions may be directed to the ImmunoChemistry department using the “contact us” link above.
Antiphospholipid Antibody Syndrome Panel – Epic Code: #LAB1230572, Interface: #1230572
Beta-2 Glycoprotein, IgG and IgM Antibodies – Epic Code: #LAB1230554, Interface: #1230554, CPT: #86146 x2
Discontinued Test: Beta-2 Glycoprotein 1 Antibodies, IgG and IgM Serum to Mayo Clinic Laboratories – Epic Code: #LAB2111339, Interface: #11461, CPT:86146 x2